Vaccines

Walgreens shares have best day since 2022

The new CEO of Walgreens Boots Alliance will help steer a massive cost-cutting plan as the drug-store chain attempts to stop losing money and as demand from COVID related products wains.

Johnson & Johnson fourth-quarter earnings down 25%

The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.